selected scholarly activity
-
conferences
- Individualized faricimab dosing up to every 16 weeks maintains robust anatomic and vision outcomes through 2 years in nAMD. Investigative Ophthalmology and Visual Science. 2023
- Two-year results from a global observational study investigating proactive dosing regimens with intravitreal aflibercept in neovascular age-related macular degeneration (nAMD) in routine clinical practice: the XTEND study. Investigative Ophthalmology and Visual Science. 2023
- Success of the Canadian Ophthalmological Society’s first virtual meeting amid COVID-19 pandemic. Canadian Journal of Ophthalmology. 131-135. 2023
- Telemedicine for Diabetic Retinopathy Screening in Low- and Middle-Income Countries: A Systematic Review and Bibliometric Analysis. Investigative Ophthalmology and Visual Science. 2022
- Retinal Displacement after Pneumatic Retinopexy versus Vitrectomy for Rhegmatogenous Retinal Detachment (ALIGN). Ophthalmology (Rochester, Minn.). 458-461. 2022
- Association between visual acuity and intraretinal (IRF) or subretinal (SRF) fluid inpatients with neovascular age-related macular degeneration (nAMD) treated with intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E): a post-hoc analysis of the ARIES study. Investigative Ophthalmology and Visual Science. 2021
- Long-term efficacy and treatment burden of treat-and-extend versus fixed or PRN regimens for nAMD: a systematic review and meta-analysis. Investigative Ophthalmology and Visual Science. 2021
- Supplemental scleral buckle for the management of rhegmatogenous retinal detachment by pars plana vitrectomy: A systematic review and meta-analysis of randomized controlled trials. Investigative Ophthalmology and Visual Science. 2021
- Characteristics and Fate of Systematic Reviews and Meta-analyses over 5 years: ARVO 2010-2014. Investigative Ophthalmology and Visual Science. 2020
- Prognostic role of baseline retinal fluids on visual acuity in patients with Wet-AMD: Systematic review. Investigative Ophthalmology and Visual Science. 2020
- 5 Pearls of Early Treatment in BRVO. Investigative Ophthalmology and Visual Science. 2017
- CD5-1 Serum extra domain B containing fibronectin (EDB FN) — a biomarker for proliferative diabetic retinopathy. Diabetes Research and Clinical Practice. S38-S38. 2008
- Increased serum EDB fibronectin in proliferative diabetic retinopathy. Diabetes. A220-A220. 2007
- The effect of triamcinolone acetonide as an adjunctive treatment to verteporfin therapy in neovascular age-related macular degeneration: A prospective, randomized, placebo controlled pilot clinical trial. Investigative Ophthalmology and Visual Science. 2005
- Nembutal and Telazol have different effects on the electroretinogram (ERG) in the rat.. Investigative Ophthalmology and Visual Science. S72-S72. 2001
-
journal articles
- Risk assessment models: considerations prior to use in clinical practice.. Eye. 2024
- Reattachment rate with pneumatic retinopexy versus pars plana vitrectomy for single break rhegmatogenous retinal detachment.. British Journal of Ophthalmology. 109:113-118. 2024
- Pilot and feasibility studies in ophthalmology: fundamental keys to success.. Eye. 1-3. 2024
- Exploring the fragility of meta-analyses in ophthalmology: a systematic review. Eye. 38:3153-3160. 2024
- Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration.. Eye. 1-10. 2024
- Integrated Assessment of OCT, Multimodal Imaging, and Cytokine Markers for Predicting Treatment Responses in Retinal Vein Occlusion Associated Macular Edema: A Comparative Review of Anti-VEGF and Steroid Therapies.. Diagnostics. 14:1983. 2024
- Facedown Positioning in Macular Hole Surgery: A Systematic Review and Individual Participant Data Meta-Analysis. Ophthalmology (Rochester, Minn.). S0161-6420(24)00483-4. 2024
- Impact of COVID-19 on a real-world treat-and-extend regimen with aflibercept for neovascular age-related macular degeneration. Canadian Journal of Ophthalmology. S0008-4182(24)00169-8. 2024
- Outcomes of Post-Cataract Surgery Endophthalmitis Managed Without Microbial Cultures. Ophthalmology Retina. S2468-6530(24)00338-5. 2024
- Correction: Retinal non-perfusion: recognizing and defining what is important. Eye. 38:1782-1782. 2024
- Retinal non-perfusion: recognizing and defining what is important. Eye. 38:1608-1609. 2024
- The ophthalmologist’s guide to evaluating the certainty of evidence using the GRADE approach. Eye. 38:1601-1604. 2024
- Imaging Predictors of Functional Outcomes after Rhegmatogenous Retinal Detachment Repair.. Retina. 44:1758-1765. 2024
- Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice. Ophthalmology Science. 4:100442-100442. 2024
- The effect of complement C3 or C5 inhibition on geographic atrophy secondary to age-related macular degeneration: A living systematic review and meta-analysis. Survey of Ophthalmology. 69:349-361. 2024
- Understanding network meta-analysis methodology for the ophthalmologist. Current Opinion in Ophthalmology. 35:260-264. 2024
- Comparing an electronic clinical information transfer system to traditional fax referrals for patients with suspected neovascular age-related macular degeneration or diabetic macular edema. Canadian Journal of Ophthalmology. 59:e614-e615. 2024
- Outcomes of Eyes Lost to Follow-up After Treatment With Intraocular or Periocular Steroid Injections. Journal of VitreoRetinal Diseases. 8:144-151. 2024
- Subthreshold Compared with Threshold Macular Photocoagulation for Diabetic Macular Edema. Ophthalmology Retina. 8:223-233. 2024
- XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration. Ophthalmology and Therapy. 13:725-738. 2024
- Anti‐vascular endothelial growth factor therapy and retinal non‐perfusion in diabetic retinopathy: A meta‐analysis of randomised trials. Acta Ophthalmologica. 102:e31-e41. 2024
- Editor-in-Chief's report: 2023 at CJO. Canadian Journal of Ophthalmology. 59:1-2. 2024
- Evaluation of postoperative ophthalmology patient instructions from ChatGPT and Google Search. Canadian Journal of Ophthalmology. 59:e69-e71. 2024
- Duration of face down positioning following full-thickness macular hole repair: A protocol for a randomized pilot study.. PLoS ONE. 19:e0304566. 2024
- Five-Year Clinical Outcomes of Intravitreal Bevacizumab Versus Laser Photocoagulation for ROP. Journal of Pediatric Ophthalmology and Strabismus. 61:73-74. 2024
- Treatment of geographic atrophy: an update on data related to pegcetacoplan. Current Opinion in Ophthalmology. 35:64-72. 2024
- Correction: The 5 min meta-analysis: understanding how to read and interpret a forest plot. Eye. 37:3704-3704. 2023
- Large language models and their impact in ophthalmology. The Lancet Digital Health. 5:e917-e924. 2023
- Patient-Reported Outcome Measure Use in Guidelines Published by the American Academy of Ophthalmology. Ophthalmology (Rochester, Minn.). 130:1201-1211. 2023
- What makes a good survey?. Eye. 37:3299-3301. 2023
- Interpreting results from randomized controlled trials: What measures to focus on in clinical practice. Eye. 37:3055-3058. 2023
- Noninferiority randomised trials in ophthalmology. Eye. 37:3059-3060. 2023
- The need for a pragmatic, individualized treat-and-extend (T&E) treatment paradigm for centre-involving diabetic macular oedema. Eye. 37:2431-2433. 2023
- Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trials. Eye. 37:1966-1974. 2023
- Twitter use by ophthalmology journals and its impact on citations. JFO Open Ophthalmology. 2:100024-100024. 2023
- Demographic and Socioeconomic Factors in Prospective Retina-Focused Clinical Trial Screening and Enrollment. Journal of Personalized Medicine. 13:880-880. 2023
- Correction to: Risk of bias: why measure it, and how?. Eye. 37:1516-1516. 2023
- Correction to: The clinician’s guide to p values, confidence intervals, and magnitude of effects. Eye. 37:1515-1515. 2023
- Global Prevalence of Diabetic Retinopathy in Pediatric Type 2 Diabetes. JAMA network open. 6:e231887-e231887. 2023
- Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next?. Eye. 37:581-583. 2023
- Editor-in-Chief's report: 2022 at CJO. Canadian Journal of Ophthalmology. 58:1-1. 2023
- Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis. Eye. 37:6-16. 2023
- Multi-center validation of Catquest-9SF visual function questionnaire in Ontario, Canada. PLoS ONE. 18:e0278863-e0278863. 2023
- Role of Positioning after Full-Thickness Macular Hole Surgery. Ophthalmology Retina. 7:33-43. 2023
- ODP185 Diabetic Retinopathy Prevalence in Pediatric Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Journal of the Endocrine Society. 6:A308-A308. 2022
- Sensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis. Eye. 36:2073-2074. 2022
- When to believe a subgroup analysis: revisiting the 11 criteria. Eye. 36:2075-2077. 2022
- Seasonal and Environmental Variations in Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor Injection: A Six-year Review. Current Eye Research. 47:1288-1293. 2022
- Incidence and Visual Outcomes of Endophthalmitis After Intravitreal Injection of Dexamethasone Implant vs Ranibizumab. Journal of VitreoRetinal Diseases. 6:358-366. 2022
- The clinician’s guide to interpreting a regression analysis. Eye. 36:1715-1717. 2022
- Treat-and-extend versus alternate dosing strategies with anti-vascular endothelial growth factor agents to treat center involving diabetic macular edema: A systematic review and meta-analysis of 2,346 eyes. Survey of Ophthalmology. 67:1346-1363. 2022
- Treat‐and‐extend regimens of anti‐vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta‐analysis. Acta Ophthalmologica. 100:e1199-e1208. 2022
- A MULTICENTER REVIEW EVALUATING THE RISK OF RHEGMATOGENOUS RETINAL DETACHMENT POST ENDOPHTHALMITIS. Retina. 42:1503-1511. 2022
- A clinician’s guide to network meta-analysis. Eye. 36:1523-1526. 2022
- Measuring atrophy in age-related macular degeneration: why does reliability matter?. Eye. 36:1527-1528. 2022
- Seeing the patient’s perspective: a guide to patient-reported outcome measures and minimal important differences in ophthalmic research. Eye. 36:1339-1341. 2022
- Association Between Visual Acuity and Fluid Compartments with Treat-and-Extend Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: An ARIES Post Hoc Analysis. Ophthalmology and Therapy. 11:1119-1130. 2022
- Guidelines for patient management: considerations before adoption into practice. Eye. 36:1135-1137. 2022
- Cohort studies investigating the effects of exposures: key principles that impact the credibility of the results. Eye. 36:905-906. 2022
- Complications of intravitreal injections: 2022. Current Opinion in Ophthalmology. 33:137-146. 2022
- Publication trends in telemedicine research originating from Canada. Healthcare Management Forum. 35:153-160. 2022
- The 12- and 24-Month Effects of Intravitreal Ranibizumab, Aflibercept, and Bevacizumab on Intraocular Pressure. Ophthalmology (Rochester, Minn.). 129:498-508. 2022
- IMPACT OF FLUID COMPARTMENTS ON FUNCTIONAL OUTCOMES FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 42:589-606. 2022
- The 5 min meta-analysis: understanding how to read and interpret a forest plot. Eye. 36:673-675. 2022
- The clinician’s guide to randomized trials: interpretation. Eye. 36:481-482. 2022
- Editor-in-Chief's report: 2021 at CJO. Canadian Journal of Ophthalmology. 57:1-1. 2022
- Risk of bias: why measure it, and how?. Eye. 36:346-348. 2022
- The clinician’s guide to p values, confidence intervals, and magnitude of effects. Eye. 36:341-342. 2022
- Supplemental Scleral Buckle for the Management of Rhegmatogenous Retinal Detachment by Pars Plana Vitrectomy: A Meta-Analysis of Randomized Controlled Trials. Ophthalmologica. 245:101-110. 2022
- The associations between central serous chorioretinopathy and muscle relaxants: A case–control study. Taiwan Journal of Ophthalmology. 12:415-415. 2022
- Recours au télédépistage pour la rétinopathie diabétique. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E1408-E1409. 2021
- Identifying gaps in patient access to diabetic screening eye examinations in Ontario: a provincially representative cross-sectional study. Canadian Journal of Ophthalmology. 56:223-230. 2021
- Maculopathie causée par le polysulfate de pentosan. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E1147-E1148. 2021
- Teleretina screening for diabetic retinopathy. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E1006-E1006. 2021
- Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in Central Retinal Vein Occlusion: the CENTERA Study. American Journal of Ophthalmology. 227:106-115. 2021
- Maculopathy caused by pentosan polysulfate. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E645-E645. 2021
- The Impact of Bariatric Surgery on Diabetic Retinopathy: A Systematic Review and Meta-Analysis. American Journal of Ophthalmology. 225:117-127. 2021
- Baseline Diabetes Knowledge Assessment Amongst Adults With Type 1 and Type 2 Diabetes Receiving Eye Care at a Tertiary Ophthalmic Centre in Canada. Canadian Journal of Diabetes. 45:22-26. 2021
- Editor-in-Chief's report: 2020 at CJO. Canadian Journal of Ophthalmology. 56:1-1. 2021
- National survey of Canadian Retina Society members on guidelines for ophthalmic care during the COVID-19 crisis: Canadian Retina Research Network (CR2N) COVID-19 Steering Committee analysis. Canadian Journal of Ophthalmology. 55:452-454. 2020
- Sedation during vitreoretinal surgery: practice patterns in Canada. Canadian Journal of Anaesthesia. 67:1439-1441. 2020
- The importance of robust research methodology in the era of COVID-19 and beyond. Canadian Journal of Ophthalmology. 55:347-348. 2020
- Characteristics and trends in publications of abstracts presented at the Canadian Ophthalmological Society Annual Meetings: 2010–2015. Canadian Journal of Ophthalmology. 55:221-231. 2020
- Endogenous Bacterial Chorioretinal Abscess Presenting With Unusual Retinal Pigment Epithelial Excrescences and Large Subretinal Hemorrhage. Retina. 40:e28-e29. 2020
- Retinal Displacement Following Pneumatic Retinopexy vs Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment. JAMA ophthalmology. 138:652-652. 2020
- Validation and application of Catquest-9SF in various populations: A systematic review. Survey of Ophthalmology. 65:348-360. 2020
- Does patient education improve compliance to routine diabetic retinopathy screening?. Journal of Telemedicine and Telecare. 26:161-173. 2020
- Ophthalmology referral as part of a multidisciplinary approach to suspected abusive head trauma. Canadian Journal of Ophthalmology. 55:172-178. 2020
- Evidence-based Canadian guidelines for tele-retina screening for diabetic retinopathy: recommendations from the Canadian Retina Research Network (CR2N) Tele-Retina Steering Committee. Canadian Journal of Ophthalmology. 55:14-24. 2020
- Tele-retina screening for diabetic retinopathy. Canadian Journal of Ophthalmology. 55:1-1. 2020
- Evaluating patient preparedness for cataract surgery and satisfaction with preoperative care. Canadian Journal of Ophthalmology. 54:458-466. 2019
- Year in Review. Canadian Journal of Ophthalmology. 54:407-407. 2019
- Increased incidence of retinopathy of prematurity and evolving treatment modalities at a Canadian tertiary centre. Canadian Journal of Ophthalmology. 54:269-274. 2019
- Ophthalmology referrals from optometry: a comparative study (the R.O.C.S study). Canadian Journal of Ophthalmology. 53:491-496. 2018
- Message de bienvenue du nouveau rédacteur en chef. Canadian Journal of Ophthalmology. 53:192-192. 2018
- Welcome message from the new Editor-in-Chief. Canadian Journal of Ophthalmology. 53:191-191. 2018
- Patient satisfaction with wait times at an emergency ophthalmology on-call service. Canadian Journal of Ophthalmology. 53:110-116. 2018
- Genetic Risk Factors Are Not Associated with Wet Age-Related Macular Degeneration Treatment Response to Ranibizumab. Ophthalmologica. 239:240-240. 2018
- Discrepancies in physician–patient agreement in reporting ocular history. Canadian Journal of Ophthalmology. 51:378-381. 2016
- Ozurdex in age-related macular degeneration as adjunct to ranibizumab (The OARA Study). Canadian Journal of Ophthalmology. 51:302-305. 2016
- Predictors of functional vision changes after cataract surgery: the PROVISION study. Canadian Journal of Ophthalmology. 51:265-270. 2016
- Ophthalmic referrals from emergency wards—a study of cases referred for urgent eye care (The R.E.S.C.U.E Study). Canadian Journal of Ophthalmology. 51:174-179. 2016
- Waiting room educational media effect on preinjection anxiety for initial intravitreal injections. Canadian Journal of Ophthalmology. 51:71-75. 2016
- Genetic Risk Evaluation in Wet Age-Related Macular Degeneration Treatment Response. Ophthalmologica. 236:88-94. 2016
- Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus. Ophthalmologica. 234:6-25. 2015
- Zone I and posterior zone II retinopathy of prematurity. Journal of Clinical Neonatology. 4:237-237. 2015
- Incidence of Retinopathy of Prematurity and Risk Factors Among Premature Infants at a Neonatal Intensive Care Unit in Canada. Journal of Pediatric Ophthalmology and Strabismus. 50:27-32. 2013
- Re-operation of idiopathic full-thickness macular holes after initial surgery with internal limiting membrane peel. British Journal of Ophthalmology. 95:1564-1567. 2011
- VALUE-BASED MEDICINE COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS ANALYSES. Evidence-Based Ophthalmology. 12:160-167. 2011
- Ranibizumab and the eye. CANADIAN MEDICAL ASSOCIATION JOURNAL. 183:822-822. 2011
- Age-related macular degeneration. CANADIAN MEDICAL ASSOCIATION JOURNAL. 182:1759-1759. 2010
- ... Diabetic retinopathy. CANADIAN MEDICAL ASSOCIATION JOURNAL. 182:1646-1646. 2010
- Diabetic retinopathy. CANADIAN MEDICAL ASSOCIATION JOURNAL. 182:1646-1646. 2010
- ARE MYOPIC EYES LESS LIKELY TO HAVE DIABETIC RETINOPATHY?. Evidence-Based Ophthalmology. 11:146-147. 2010
- Are Myopic Eyes Less Likely to Have Diabetic Retinopathy?. Ophthalmology (Rochester, Minn.). 117:524-530. 2010
- Extracellular Matrix Proteins in Epiretinal Membranes and in Diabetic Retinopathy. Current Eye Research. 34:134-144. 2009
- SEQUENCE- AND TARGET-INDEPENDENT ANGIOGENESIS SUPPRESSION BY SIRNA VIA TLR3. Evidence-Based Ophthalmology. 9:242-243. 2008
- Acanthamoeba keratitis complicating orthokeratology. Clinical and Surgical Ophthalmology. 26:286-287. 2008
- Triamcinolone Acetonide as Adjunctive Treatment to Verteporfin in Neovascular Age-Related Macular Degeneration. Ophthalmology (Rochester, Minn.). 114:2183-2189. 2007
- Laser range finder can cause retinal injury.. Indian Journal of Ophthalmology. 52:169-170. 2004
- Effects of telazol and nembutal on retinal responses.. Documenta Ophthalmologica. 107:45-51. 2003
- Cellular Turnover in the Mammary Gland Is Correlated with Systemic Levels of Progesterone and Not 17β-Estradiol During the Estrous Cycle1. Biology of Reproduction. 65:680-688. 2001
- AB026. Referrals from optometry—a comparative study (the R.O.C.S study). Annals of Eye Science. 3:AB026-AB026.